Abstract:Hematopoietic stem cells (HSCs) mature from pre-HSCs that differentiate from hemogenic endothelium in the major arteries of the embryo. The transcription factor RUNX1 is expressed in hemogenic endothelium, and is required for the endothelial to hematopoietic cell transition. Hematopoietic cells newly formed from hemogenic endothelium accumulate briefly in the major arteries in clusters before being released into the circulation to colonize the fetal liver. We used the 10X Genomics platform to perform scRNA-Seq on purified endothelial cells, hemogenic endothelial cells, hematopoietic cluster cells, pre-HSCs, and fetal liver HSCs at several developmental time points. Our goals are to analyze the developmental trajectory from hemogenic endothelial cells to fetal liver HSCs, identify cell surface markers of distinct cell populations, and predict signaling pathways regulating HSC formation. The scRNA-Seq analysis confirms previously published functional data generated by multiple laboratories. Hemogenic endothelium is a branch of all endothelial cells, and gives rise to at least two waves of progenitors in the major arteries; CD45+ cells with lymphoid and myeloid potential at embryonic day 10.5, followed by CD45+ pre-HSCs at E11.5. We show that these two populations are molecularly distinct, the former expressing lymphoid and myeloid genes (e.g. Il7r, Mpo, Csf1r), and the latter genes associated with HSCs (Procr, Mecom). We furthermore show that RUNX1, which is absolutely required for HSC formation, appears to specify, but not to commit a hemogenic endothelial cell to the blood lineage.

Hematopoietic Cell Formation in the Major Arteries of the Mouse Embryo